189 related articles for article (PubMed ID: 23303449)
1. CtBP1 is expressed in melanoma and represses the transcription of p16INK4a and Brca1.
Deng H; Liu J; Deng Y; Han G; Shellman YG; Robinson SE; Tentler JJ; Robinson WA; Norris DA; Wang XJ; Zhang Q
J Invest Dermatol; 2013 May; 133(5):1294-301. PubMed ID: 23303449
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer.
Deng Y; Deng H; Liu J; Han G; Malkoski S; Liu B; Zhao R; Wang XJ; Zhang Q
Mol Carcinog; 2012 Jun; 51(6):500-7. PubMed ID: 21681822
[TBL] [Abstract][Full Text] [Related]
3. Redox-dependent Brca1 transcriptional regulation by an NADH-sensor CtBP1.
Deng Y; Liu J; Han G; Lu SL; Wang SY; Malkoski S; Tan AC; Deng C; Wang XJ; Zhang Q
Oncogene; 2010 Dec; 29(50):6603-8. PubMed ID: 20818429
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines.
Deng Y; Deng H; Bi F; Liu J; Bemis LT; Norris D; Wang XJ; Zhang Q
Int J Biol Sci; 2011 Jan; 7(1):133-7. PubMed ID: 21278922
[TBL] [Abstract][Full Text] [Related]
5. Loss of full length CtBP1 expression enhances the invasive potential of human melanoma.
Winklmeier A; Poser I; Hoek KS; Bosserhoff AK
BMC Cancer; 2009 Feb; 9():52. PubMed ID: 19216735
[TBL] [Abstract][Full Text] [Related]
6. C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells.
Deng Y; Li H; Yin X; Liu H; Liu J; Guo D; Shi Z
Med Sci Monit; 2018 Oct; 24():7614-7624. PubMed ID: 30356033
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA485-3p negatively regulates the transcriptional co-repressor
Du K; Zhang X; Lou Z; Guo P; Zhang F; Wang B; Chen L; Zhang C
Int J Biol Sci; 2018; 14(11):1445-1456. PubMed ID: 30262996
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
[TBL] [Abstract][Full Text] [Related]
9. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Deng Y; Guo W; Xu N; Li F; Li J
Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
[TBL] [Abstract][Full Text] [Related]
10. The CtBP1-p300-FOXO3a transcriptional complex represses the expression of the apoptotic regulators Bax and Bim in human osteosarcoma cells.
Li C; Xiao XQ; Qian YH; Zhou ZY
J Cell Physiol; 2019 Dec; 234(12):22365-22377. PubMed ID: 31074088
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of COOH-terminal binding protein expression in malignant melanomas leads to induction of MIA expression.
Poser I; Golob M; Weidner M; Buettner R; Bosserhoff AK
Cancer Res; 2002 Oct; 62(20):5962-6. PubMed ID: 12384563
[TBL] [Abstract][Full Text] [Related]
12. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
[TBL] [Abstract][Full Text] [Related]
13. p16INK4a suppresses BRCA1-deficient mammary tumorigenesis.
Scott A; Bai F; Chan HL; Liu S; Ma J; Slingerland JM; Robbins DJ; Capobianco AJ; Pei XH
Oncotarget; 2016 Dec; 7(51):84496-84507. PubMed ID: 27811360
[TBL] [Abstract][Full Text] [Related]
14. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
[TBL] [Abstract][Full Text] [Related]
15. CtBP1 overexpression in keratinocytes perturbs skin homeostasis.
Deng H; Li F; Li H; Deng Y; Liu J; Wang D; Han G; Wang XJ; Zhang Q
J Invest Dermatol; 2014 May; 134(5):1323-1331. PubMed ID: 24280726
[TBL] [Abstract][Full Text] [Related]
16. Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells.
Bai M; Yu NZ; Long F; Feng C; Wang XJ
Cell Physiol Biochem; 2016; 40(6):1367-1376. PubMed ID: 27997910
[TBL] [Abstract][Full Text] [Related]
17. p16INK4A expression in malignant melanomas with or without a contiguous naevus remnant: a clue to their divergent pathogenesis?
Winnepenninckx V; van den Oord JJ
Melanoma Res; 2004 Aug; 14(4):321-2. PubMed ID: 15305164
[No Abstract] [Full Text] [Related]
18. Role of transcriptional corepressor CtBP1 in prostate cancer progression.
Wang R; Asangani IA; Chakravarthi BV; Ateeq B; Lonigro RJ; Cao Q; Mani RS; Camacho DF; McGregor N; Schumann TE; Jing X; Menawat R; Tomlins SA; Zheng H; Otte AP; Mehra R; Siddiqui J; Dhanasekaran SM; Nyati MK; Pienta KJ; Palanisamy N; Kunju LP; Rubin MA; Chinnaiyan AM; Varambally S
Neoplasia; 2012 Oct; 14(10):905-14. PubMed ID: 23097625
[TBL] [Abstract][Full Text] [Related]
19. Inverse correlation between p16INK4A expression and NF-kappaB activation in melanoma progression.
Ghiorzo P; Mantelli M; Gargiulo S; Gramigni C; Pastorino L; Banelli B; Villaggio B; Coccia MC; Sementa AR; Garrè C; Bianchi-Scarrà G
Hum Pathol; 2004 Aug; 35(8):1029-37. PubMed ID: 15297971
[TBL] [Abstract][Full Text] [Related]
20. Contribution of CDKN2A/P16 ( INK4A ), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma.
Buecher B; Gauthier-Villars M; Desjardins L; Lumbroso-Le Rouic L; Levy C; De Pauw A; Bombled J; Tirapo C; Houdayer C; Bressac-de Paillerets B; Stoppa-Lyonnet D
Fam Cancer; 2010 Dec; 9(4):663-7. PubMed ID: 20842456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
